Kineta Shares Are Trading Higher After the Company Announced It Reopened Patient Enrollment for Its VISTA-101 Clinical Trial.
Kineta Shares Are Trading Higher After the Company Announced It Reopened Patient Enrollment for Its VISTA-101 Clinical Trial.
Kineta公司宣佈重新開放VISTA-101臨床試驗的患者招募後，其股票價格上漲。
Kineta Shares Are Trading Higher After the Company Announced It Reopened Patient Enrollment for Its VISTA-101 Clinical Trial.
Kineta公司宣佈重新開放VISTA-101臨床試驗的患者招募後，其股票價格上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
